Growth Metrics

Biote (BTMD) Shares Outstanding (Diluted Average) (2020 - 2021)

Biote's quarterly Shares Outstanding (Diluted Average) came in at $26.3 million in Q4 2021, up 250.2% year-on-year from $7.5 million in Q4 2020, and up 250.2% quarter-over-quarter from $7.5 million in Q4 2020.

Biote has reported Shares Outstanding (Diluted Average) for 2 years, with the latest figure at $26.3 million in Q4 2021.

  • For the quarter ending Q4 2021, Shares Outstanding (Diluted Average) rose 250.2% year-over-year to $26.3 million; the trailing twelve-month figure through Dec 2021 stood at $26.3 million (up 250.2% YoY), and the FY2021 full-year result was $26.3 million, up 250.2% from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2021 stood at $26.3 million, up from $7.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $26.3 million in Q4 2021, with the low at $7.5 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 87.60 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 68.88 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 100.60 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 59.57 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 597,000.00
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 162.08 Mn
10 Biote 61.29 Mn 64.11 Mn 30.95 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 26.27 Mn
Dec 31, 2020 7.50 Mn